BSE filing, NSE: CEETAIN. Summary written from the filing by ALFA Finder's alert engine.
Ceeta Industries Ltd: key numbers
- Share price
- ₹37.00
- Market cap
- ₹53.66 Cr
- Revenue (annual)
- ₹21.36 Cr
- Net profit (annual)
- ₹0.59 Cr
- P/E (TTM)
- 72.7×Sector 40.4×
- Promoter holding
- 71.91%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Ceeta Industries Ltd
All →Ceeta Industries Board Meeting Date
Ceeta Industries intimated a board meeting on November 12, 2026 to consider unaudited Q2 and half-year results. The filing also notes the trading window remains closed for designated persons.
Ceeta Industries Other Announcement
Ceeta Industries Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI Regulation 31(1)(b).
Ceeta Industries Management Change
Ceeta Industries Ltd reported the sad demise of Mr. Bal Krishna Bhalotia, an Independent Director of the company, effective October 1, 2026.
Ceeta Industries Other Announcement
Ceeta Industries sent a KYC updation reminder to physical-mode shareholders. It details mandatory Forms ISR-1/2 and nomination requirements under the SEBI circular.
Ceeta Industries Annual General Meeting
Ceeta Industries held its 42nd Annual General Meeting on August 25, 2026. Shareholders transacted ordinary and special business items as outlined in the AGM notice.
Ceeta Industries Q1 FY27 Results: Net Profit ₹0.5 Cr, Up 66.7% YoY
Ceeta Industries Ltd reported revenue from operations of ₹4.7 Cr (-20.3% YoY) and net profit of ₹0.5 Cr (+66.7% YoY) for Q1 FY27.
- Key figure
- Net profit ₹0.5 Cr · +66.7% YoY
Other other announcement announcements
All →Shukra Pharmaceuticals Other Announcement
Shukra Medtech confirmed no deviation in the use of funds from its preferential convertible warrant issue. The company received ₹10.46 Crore, 75% of the consideration, from allottees.
- Value
- ₹10.46 Cr
Krishna Institute of Medical Sciences Other Announcement
KIMS's CARE Ratings monitoring report shows ₹1,311.81 crore of the ₹1,476.45 crore QIP proceeds utilised till Q2 FY27. No deviation from the stated objects was reported.
Transchem Other Announcement
Transchem's monitoring agency reports no deviation in warrant proceeds utilisation for the quarter ended September 2026. No material facts were flagged.
Archidply Industries Other Announcement
Archidply Industries disclosed that its RTA, KFin Technologies, is shifting its corporate office to Kokapet, Hyderabad from December 1, 2026. The registered office is unchanged and shareholders should update correspondence addresses.
KEI Industries Other Announcement
Designated person Jashobant Singha Ray pledged 1,500 KEI Industries shares. After the transaction, 10,000 of his 18,000 shares are pledged, with no cash consideration disclosed.
Kansai Nerolac Paints Other Announcement
Kansai Nerolac authorised Pravin Chaudhari, Yash Ahuja and Rukmini Subramanian to determine material events from 1 December 2026. It only lists KMP and contact details.